BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 17, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Feb. 6, 2007
View Archived Issues
Novel antiinfective agents disclosed in recent patent literature
Read More
Snapshots from the 2007 Gastrointestinal Cancers Symposium: Part I
Read More
CF-101 studied for dry eye syndrome in new phase II study
Read More
ND-0601 transdermal levodopa patch completes pilot study
Read More
DiaKine Therapeutics and AdPharma to develop pipeline for reversing diabetes
Read More
Methylphenidate to commence clinical trial for the treatment of cancer-related fatigue
Read More
Johnson & Johnson completes acquisition of Conor Medsystems
Read More
Starpharma continues studies of microbicide VivaGel
Read More
DelSite licenses technology to AriaVax for HIV vaccine
Read More
Progress reported in Riquent phase III study
Read More
KI-23057 shows preclinical activity against different types of cancer
Read More
Neurochem completes North American phase III study of tramiprosate
Read More
Generex begins phase II trial for AE-37 in breast cancer
Read More
Shionogi and Lilly to codevelop and comarket duloxetine in Japan
Read More
Losartan normalizes muscle architecture, repair and function in mouse models of myopathic disorders
Read More
Blockade of the orexin OX1/OX2 receptors with ACT-078573 promotes sleep in rats, dogs and humans
Read More
Mitsubishi Pharma to merge with Tanabe Seiyaku
Read More
Schering-Plough licenses AN-2690 for onychomycosis
Read More
Bioral amphotericin set to begin clinical testing
Read More
Pivotal Acapodene trials recommended to continue
Read More
KI-26894: a novel inhibitor of TGF-beta receptor inhibits tumor growth and prolongs survival in mice
Read More
RTP-801i for wet AMD begins phase I study
Read More
Erbitux filed in Japan for metastatic colorectal cancer
Read More
Recent patents report novel therapeutic agents for metabolic diseases
Read More
Wyeth and Nautilus to develop recombinant Factor IX proteins for hemophilia B
Read More
Genta completes response to EMEA for Genasense MAA in advanced melanoma
Read More
Virginia Commonwealth University and Nicogen jointly divulge novel antismoking agents
Read More